High prevalence of the MLH1 V384D germline mutation in patients with HER2-positive luminal B breast cancer

HER2-positive luminal B breast cancer (BC), a subset of the luminal B subtype, is ER-positive and HER2-positive BC which is approximately 10% of all BC. However, HER2-positive luminal B BC has received less attention and is less represented in previous molecular analyses than other subtypes. Hence,...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Seung Eun, Lee, Hye Seung, Kim, Kyoung-Yeon, Park, Jung-Hoon, Roh, Hanseong, Park, Ha Young, Kim, Wan-Seop
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6662670/
https://www.ncbi.nlm.nih.gov/pubmed/31358837
http://dx.doi.org/10.1038/s41598-019-47439-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6662670/
https://www.ncbi.nlm.nih.gov/pubmed/31358837
http://dx.doi.org/10.1038/s41598-019-47439-3

Ejemplares similares